Primary Site >> Liver Cancer
Gene >> ITK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody. PMID: 3942992 |
Ref: Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. PMID: 7850925 |
Ref: Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. PMID: 9923973 |
Ref: In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. PMID: 17920762 Ref: Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. PMID: 17987801 Ref: Molecular pathways and related target therapies in liver carcinoma. PMID: 18045179 |
Ref: The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2. PMID: 18183498 Ref: Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. PMID: 18381447 |
Ref: Molecular genetics of hepatocellular neoplasia. PMID: 20182587 Ref: Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. PMID: 20564331 |
Ref: The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4alpha. PMID: 21384409 Ref: Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging. PMID: 21531287 |
Ref: Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia. PMID: 22088439 Ref: Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines. PMID: 22179686 Ref: Cross-talk between TGFbeta1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. PMID: 22292774 Ref: Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling. PMID: 22337876 Ref: Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. PMID: 22393452 Ref: Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B. PMID: 22510613 Ref: GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. PMID: 22847784 Ref: Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells. PMID: 22993319 Ref: The transcription factor GLI1 mediates TGFbeta1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism. PMID: 23185371 Ref: Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. PMID: 23227088 Ref: miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma. PMID: 23552699 |
Ref: TGFbeta overrides HNF4alpha tumor suppressing activity through GSK3beta inactivation: implication for hepatocellular carcinoma gene therapy. PMID: 22960426 Ref: Cancer genetics and genomics of human FOX family genes. PMID: 23022474 Ref: Claudin-1 as a promoter of EMT in hepatocellular carcinoma. PMID: 23318416 Ref: KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. PMID: 23504025 Ref: HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells. PMID: 23599793 Ref: MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. PMID: 23725476 Ref: CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma. PMID: 23756565 Ref: Induction of an EMT-like transformation and MET in vitro. PMID: 23829659 Ref: miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. PMID: 23864307 Ref: LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. PMID: 24093956 Ref: Hypoxia promotes epithelial--mesenchymal transition of hepatocellular carcinoma cells via inducing GLIPR-2 expression. PMID: 24204846 Ref: Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. PMID: 24240095 Ref: Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). PMID: 24304617 Ref: The cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cells. PMID: 24383061 |
Ref: Features of massive hepatocellular carcinomas. PMID: 23863262 Ref: Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition. PMID: 24078466 Ref: Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. PMID: 24135722 Ref: Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. PMID: 24247585 Ref: Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. PMID: 24376083 Ref: Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression. PMID: 24378923 Ref: Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma. PMID: 24409330 Ref: Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation. PMID: 24465159 Ref: Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. PMID: 24512821 Ref: The aPKCiota blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma. PMID: 24651432 Ref: HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. PMID: 24840636 Ref: Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma. PMID: 24884809 Ref: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 24892648 Ref: MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PMID: 24992599 Ref: Potential involvement of chemicals in liver cancer progression: an alternative toxicological approach combining biomarkers and innovative technologies. PMID: 24997295 Ref: CAV1 promotes HCC cell progression and metastasis through Wnt/beta-catenin pathway. PMID: 25180681 Ref: Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer. PMID: 25182808 Ref: Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. PMID: 25189528 Ref: Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma. PMID: 25277383 Ref: Twist-1 up-regulation in carcinoma correlates to poor survival. PMID: 25429425 Ref: STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells. PMID: 26158169 Ref: AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer. PMID: 26351209 Ref: Current understanding of tyrosine kinase BMX in inflammation and its inhibitors. PMID: 27602372 |
Ref: HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-beta1 pathway in hepatocellular carcinoma cells. PMID: 25081022 Ref: Hypoxia up-regulates SERPINB3 through HIF-2alpha in human liver cancer cells. PMID: 25544768 Ref: SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 25619838 Ref: Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma. PMID: 25628925 Ref: STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. PMID: 25653024 Ref: Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. PMID: 25668006 Ref: Establishment of a novel system for the culture and expansion of hepatic stem-like cancer cells. PMID: 25676692 Ref: Enhancing HOTAIR/MiR-10b Drives Normal Liver Stem Cells Toward a Tendency to Malignant Transformation Through Inducing Epithelial- to-Mesenchymal Transition. PMID: 25708830 Ref: Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44. PMID: 25772760 Ref: Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. PMID: 25808945 Ref: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway. PMID: 25908926 Ref: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells. PMID: 25909289 Ref: MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. PMID: 25931210 Ref: MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. PMID: 25953743 Ref: miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail. PMID: 26035427 Ref: miR-145 regulates chemoresistance in hepatocellular carcinoma via epithelial mesenchymal transition. PMID: 26068913 Ref: MiR-101 targets DUSP1 to regulate the TGF-beta secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. PMID: 26158762 Ref: TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection. PMID: 26190376 Ref: Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/beta-catenin signaling. PMID: 26208456 Ref: DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. PMID: 26362312 Ref: Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. PMID: 26404322 Ref: AMPK Inhibits the Stimulatory Effects of TGF-beta on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition. PMID: 26424816 Ref: Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. PMID: 26452542 Ref: Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. PMID: 26536663 Ref: Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? PMID: 26703747 Ref: Combinatorial interventions inhibit TGFbeta-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes. PMID: 28725463 |
Ref: Combination therapy with local radiofrequency ablation and YC-1 inhibits the proliferation and metastasis of hepatocellular carcinoma through activating beta-catenin signaling. PMID: 2038240 Ref: Combination therapy with local radiofrequency ablation and YC-1 inhibits the proliferation and metastasis of hepatocellular carcinoma through activating beta-catenin signaling. PMID: 14730035 Ref: MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-kappaB-mediated EMT. PMID: 26188902 Ref: Overexpression of OCT4 contributes to progression of hepatocellular carcinoma. PMID: 26508029 Ref: An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer. PMID: 26540342 Ref: Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma. PMID: 26594798 Ref: Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma. PMID: 26718209 Ref: Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/beta-catenin activation. PMID: 26778753 Ref: AP-2alpha inhibits hepatocellular carcinoma cell growth and migration. PMID: 26780928 Ref: The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1. PMID: 26808085 Ref: Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma. PMID: 26820712 Ref: Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis. PMID: 26837767 Ref: AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFbeta1-ERK2 pathways. PMID: 26902423 Ref: 14-3-3zeta promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1alpha. PMID: 26910835 Ref: MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. PMID: 26944318 Ref: Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3beta/beta-catenin axis and TGF-beta induced EMT with sophocarpine. PMID: 26945965 Ref: Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1alpha via the PI3K/AKT/mTOR pathway. PMID: 26958938 Ref: Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1alpha is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. PMID: 26984380 Ref: Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma. PMID: 27002617 Ref: Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma. PMID: 27057626 Ref: TALENs-directed knockout of the full-length transcription factor Nrf1alpha that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. PMID: 27065079 Ref: Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. PMID: 27091611 Ref: An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients. PMID: 27115761 Ref: FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-beta/Smad signaling. PMID: 27177473 Ref: Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways. PMID: 27186411 Ref: The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-beta1 signaling: implications in hepatocellular carcinogenesis. PMID: 27293999 Ref: Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. PMID: 27298373 Ref: DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma. PMID: 27344963 Ref: HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of hepatocellular cancer cells. PMID: 27460728 Ref: Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. PMID: 27461522 Ref: Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a. PMID: 27542259 Ref: Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma. PMID: 27578206 Ref: Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer. PMID: 27580057 Ref: NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma. PMID: 27611941 Ref: Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/beta-catenin pathway in hepatocellular carcinoma cells. PMID: 27666874 Ref: Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma. PMID: 27697528 Ref: Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. PMID: 27765853 Ref: [The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells]. PMID: 27784456 Ref: Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis. PMID: 27806330 Ref: Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition. PMID: 27830005 Ref: Combination therapy with local radiofrequency ablation and YC-1 inhibits the proliferation and metastasis of hepatocellular carcinoma through activating beta-catenin signaling. PMID: 29441848 |
Ref: CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells. PMID: 27629543 Ref: Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling. PMID: 27705934 Ref: Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression. PMID: 27862275 Ref: miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC. PMID: 27864783 Ref: FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition. PMID: 27924058 Ref: Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells. PMID: 27935857 Ref: Overexpression of RAS-Association Domain Family 6 (RASSF6) Inhibits Proliferation and Tumorigenesis in Hepatocellular Carcinoma Cells. PMID: 27983932 Ref: Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response. PMID: 27987431 Ref: P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition. PMID: 28052026 Ref: Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells. PMID: 28073674 Ref: HINT2 downregulation promotes colorectal carcinoma migration and metastasis. PMID: 28088787 Ref: HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. PMID: 28122307 Ref: The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis. PMID: 28181686 Ref: TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma. PMID: 28256185 Ref: Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. PMID: 28282787 Ref: MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway. PMID: 28288133 Ref: Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. PMID: 28350091 Ref: NVM-1 predicts prognosis and contributes to growth and metastasis in hepatocellular carcinoma. PMID: 28401011 Ref: Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas. PMID: 28415775 Ref: Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway. PMID: 28419966 Ref: MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. PMID: 28423650 Ref: 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 28429188 Ref: HIF-1alpha promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. PMID: 28449718 Ref: Oct4 induces EMT through LEF1/beta-catenin dependent WNT signaling pathway in hepatocellular carcinoma. PMID: 28454439 Ref: Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma. PMID: 28460616 Ref: KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. PMID: 28465479 Ref: Small nucleolar RNA 47 promotes tumorigenesis by regulating EMT markers in hepatocellular carcinoma. PMID: 28466632 Ref: NFAT5 inhibits invasion and promotes apoptosis in hepatocellular carcinoma associated with osmolality. PMID: 28485155 Ref: POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma. PMID: 28489585 Ref: The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. PMID: 28549790 Ref: Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. PMID: 28560058 Ref: Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma. PMID: 28578938 Ref: Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development. PMID: 28596515 Ref: MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. PMID: 28606154 Ref: MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. PMID: 28666208 Ref: CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma. PMID: 28670372 Ref: GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis. PMID: 28698581 Ref: Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. PMID: 28716020 Ref: LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma. PMID: 28772210 Ref: Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells. PMID: 28781954 Ref: Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. PMID: 28810875 Ref: Loss-of-function of miR-142 by hypermethylation promotes TGF-beta-mediated tumour growth and metastasis in hepatocellular carcinoma. PMID: 28963738 Ref: RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186/E-cadherin/EMT pathway. PMID: 28977878 Ref: Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells. PMID: 28979676 Ref: Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma. PMID: 29025375 Ref: Murine hepatocellular carcinoma derived stem cells reveal epithelial-to-mesenchymal plasticity. PMID: 29026462 Ref: EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling. PMID: 29029500 Ref: Road to stemness in hepatocellular carcinoma. PMID: 29085221 Ref: Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide. PMID: 29096248 Ref: Design, synthesis, and anticancer properties of isocorydine derivatives. PMID: 29103873 Ref: LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer. PMID: 29113674 Ref: MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma. PMID: 29119055 Ref: microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma. PMID: 29152116 Ref: CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma. PMID: 29285247 Ref: Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma. PMID: 29375378 Ref: Exploring liver physiology, pathology, TGF-beta, EMT, stemness and new developments in liver cancer. PMID: 30191049 |
Ref: Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through beta-catenin-EGFR-PI3K-Akt-mTOR signaling pathway. PMID: 29027712 Ref: Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. PMID: 29131381 Ref: MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23. PMID: 29191386 Ref: STAT3 aggravates TGF-beta1-induced hepatic epithelial-to-mesenchymal transition and migration. PMID: 29268242 Ref: LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma. PMID: 29278875 Ref: MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. PMID: 29357919 Ref: miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition. PMID: 29403024 Ref: N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin beta1 and promotes HCC metastasis. PMID: 29431199 Ref: STK17B promotes carcinogenesis and metastasis via AKT/GSK-3beta/Snail signaling in hepatocellular carcinoma. PMID: 29445189 Ref: TGF-beta2-induced EMT is dampened by inhibition of autophagy and TNF-alpha treatment. PMID: 29464083 Ref: The role of cancer-associated fibroblast MRC-5 in pancreatic cancer. PMID: 29483967 Ref: Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis. PMID: 29520156 Ref: Autocrine transforming growth factor-beta/activin A-Smad signaling induces hepatic progenitor cells undergoing partial epithelial-mesenchymal transition states. PMID: 29544731 Ref: Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC. PMID: 29669339 Ref: MicroRNA577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1. PMID: 29693150 Ref: The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. PMID: 29706627 Ref: Chitin synthesis inhibitors promote liver cancer cell metastasis via interfering with hypoxia-inducible factor 1alpha. PMID: 29753285 Ref: Liver regeneration requires Yap1-TGFbeta-dependent epithelial-mesenchymal transition in hepatocytes. PMID: 29758331 Ref: Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. PMID: 29772429 Ref: TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation. PMID: 29789583 Ref: Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs. PMID: 29789629 Ref: High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma. PMID: 29801468 Ref: MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition. PMID: 29855744 Ref: LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. PMID: 29915311 Ref: Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway. PMID: 29928866 Ref: Farnesoid X Receptor Activation Enhances Transforming Growth Factor beta-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. PMID: 29958417 Ref: PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 30026835 Ref: AP-2beta inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition. PMID: 30026878 Ref: EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database. PMID: 30037433 Ref: ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma. PMID: 30049513 Ref: Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma. PMID: 30057891 Ref: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612. PMID: 30068940 Ref: MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9. PMID: 30070322 Ref: Hsp90beta promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 30087438 Ref: Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition. PMID: 30087705 Ref: miR-190 promotes HCC proliferation and metastasis by targeting PHLPP1. PMID: 30092222 Ref: BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. PMID: 30096458 Ref: Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl(4)-Induced Hepatic Fibrosis Animal Model. PMID: 30103395 Ref: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling. PMID: 30115976 Ref: DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway. PMID: 30119889 Ref: Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma. PMID: 30157906 Ref: Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. PMID: 30195041 Ref: HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. PMID: 30231922 Ref: PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/beta-catenin pathway. PMID: 30243081 Ref: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway. PMID: 30250300 Ref: Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis. PMID: 30257387 Ref: The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes. PMID: 30271487 Ref: Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. PMID: 30279729 Ref: The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma. PMID: 30320132 Ref: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. PMID: 30338801 Ref: SPARC acts as a mediator of TGF-beta1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells. PMID: 30346081 Ref: Inhibition of Cancer Stem Cells Promoted by Pimozide. PMID: 30383889 |